The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members’ work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
Last month, a small group of CVD & Diabetes experts from the World Heart Federation (WHF) and the International Diabetes Federation (IDF) came together at Emory University, Atlanta, to discuss the crisis of Type 2 Diabetes Mellitus and the increasing incidence of CVD. With the burden expected to rise two to four-fold by 2030, there is an urgent need to implement measures that will assist people living with diabetes, health care professionals, policymakers, health system providers and decision-makers and to consider a patient pathway that promotes prevention, awareness and lifestyle management.
The objectives of the meeting were clearly defined to detail a vision of an ideal patient pathway for CVD & Diabetes patients, to identify roadblocks along this pathway and consider solutions that could be adapted and applied across different contexts. Thanks to WHF and IDF members, this small group of experts were informed by over 150 respondents from 59 countries which allowed meeting experts to consider the perspectives from a much wider pool of international experts. This survey was the first of further planned surveys to work collaboratively with members in order to develop and propose solutions that match expectations and inform an initiative that may have a real and significant impact for early diagnosis and improved care for CVD & Diabetes patients.
We look forward to following up with the next phases of development to reduce this growing burden for patients, for families, and for our WHF & IDF members.